(S)-Amisulpride | CAS#71675-92-8

MedKoo Cat#: 526496 | Name: (S)-Amisulpride

Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

(S)-Amisulpride is a potent D2 and D3 receptor antagonist, also acting as a potent antagonist at the 5-HT7 receptor.

Chemical Structure

(S)-Amisulpride

CAS#71675-92-8 (S-isomer)

Theoretical Analysis

MedKoo Cat#: 526496

Name: (S)-Amisulpride

CAS#: 71675-92-8 (S-isomer)

Chemical Formula: C17H27N3O4S

Exact Mass: 369.1700

Molecular Weight: 369.48

Elemental Analysis: C, 55.26; H, 7.37; N, 11.37; O, 17.32; S, 8.68

Price and Availability

Size	Price	Availability	Quantity
5mg	USD 450.00	2 Weeks
10mg	USD 780.00	2 Weeks

Bulk Inquiry

Buy Now

Add to Cart

Related CAS #

81342-13-4 (HCl) 71675-85-9 (free base) 71675-92-8 (S-isomer) 71675-90-6 (R-isomer) 2129505-46-8 ( R-isomer HCl)

Synonym

(S)-Amisulpride; Esamisulpride

IUPAC/Chemical Name

(S)-4-Amino-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-(ethylsulfonyl)-2-methoxybenzamide

InChi Key

NTJOBXMMWNYJFB-LBPRGKRZSA-N

InChi Code

InChI=1S/C17H27N3O4S/c1-4-20-8-6-7-12(20)11-19-17(21)13-9-16(25(22,23)5-2)14(18)10-15(13)24-3/h9-10,12H,4-8,11,18H2,1-3H3,(H,19,21)/t12-/m0/s1

SMILES Code

O=C(NC[C@H]1N(CC)CCC1)C2=CC(S(=O)(CC)=O)=C(N)C=C2OC

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 369.48 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Kang SG, Chee IS, Chang HS, Na KS, Lee K, Lee J. Polymorphism of the SNAP25 gene is associated with symptom improvement in schizophrenic patients treated with amisulpride. Neurosci Lett. 2017 Nov 20;661:46-50. doi: 10.1016/j.neulet.2017.09.041. Epub 2017 Sep 23. PubMed PMID: 28947383. 2: Donahue TJ, Hillhouse TM, Webster KA, Young R, De Oliveira EO, Porter JH. Discriminative stimulus properties of the atypical antipsychotic amisulpride: comparison to its isomers and to other benzamide derivatives, antipsychotic, antidepressant, and antianxiety drugs in C57BL/6 mice. Psychopharmacology (Berl). 2017 Dec;234(23-24):3507-3520. doi: 10.1007/s00213-017-4738-y. Epub 2017 Sep 18. PubMed PMID: 28921163. 3: Liang Y, Yu X. Effectiveness of amisulpride in Chinese patients with predominantly negative symptoms of schizophrenia: a subanalysis of the ESCAPE study. Neuropsychiatr Dis Treat. 2017 Jun 28;13:1703-1712. doi: 10.2147/NDT.S140905. eCollection 2017. PubMed PMID: 28721051; PubMed Central PMCID: PMC5499925. 4: Graf H, Wiegers M, Metzger CD, Walter M, Grön G, Abler B. Noradrenergic modulation of neural erotic stimulus perception. Eur Neuropsychopharmacol. 2017 Sep;27(9):845-853. doi: 10.1016/j.euroneuro.2017.06.015. Epub 2017 Jul 3. PubMed PMID: 28683981. 5: Gamal W, Fahmy RH, Mohamed MI. Development of novel amisulpride-loaded solid self-nanoemulsifying tablets: preparation and pharmacokinetic evaluation in rabbits. Drug Dev Ind Pharm. 2017 Sep;43(9):1539-1547. doi: 10.1080/03639045.2017.1322608. Epub 2017 May 11. PubMed PMID: 28447882. 6: Grover S, Avasthi A, Sinha V, Lakdawala B, Bathla M, Sethi S, Mathur DM, Kathuria P, Shah S, Baalasubramanian DS, Agarwal V, Deka K. Indian psychiatric society multicentric study: Correlates of prescription patterns of psychotropics in India. Indian J Psychiatry. 2016 Oct-Dec;58(4):417-424. doi: 10.4103/0019-5545.196703. PubMed PMID: 28196999; PubMed Central PMCID: PMC5270267. 7: Skibinski R, Trawinski J. Application of an Untargeted Chemometric Strategy in the Impurity Profiling of Pharmaceuticals: An Example of Amisulpride. J Chromatogr Sci. 2017 Mar 1;55(3):309-315. doi: 10.1093/chromsci/bmw186. PubMed PMID: 27903552. 8: Gan TJ, Kranke P, Minkowitz HS, Bergese SD, Motsch J, Eberhart L, Leiman DG, Melson TI, Chassard D, Kovac AL, Candiotti KA, Fox G, Diemunsch P. Intravenous Amisulpride for the Prevention of Postoperative Nausea and Vomiting: Two Concurrent, Randomized, Double-blind, Placebo-controlled Trials. Anesthesiology. 2017 Feb;126(2):268-275. doi: 10.1097/ALN.0000000000001458. PubMed PMID: 27902493. 9: Institute for Quality and Efficiency in Health Care. Lurasidone -- Benefit Assessment According to §35a Social Code Book V [Internet]. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2015 Jan 28. Available from http://www.ncbi.nlm.nih.gov/books/NBK385744/ PubMed PMID: 27905784. 10: Kim Y, Wang SM, Kwak KP, Yoon HK, Pae CU, Kim JJ, Bahk WM. Amisulpride Switching in Schizophrenic Patients Who Showed Suboptimal Effect and/or Tolerability to Current Antipsychotics in a Naturalistic Setting: An Explorative Study. Clin Psychopharmacol Neurosci. 2016 Nov 30;14(4):371-377. doi: 10.9758/cpn.2016.14.4.371. PubMed PMID: 27776390; PubMed Central PMCID: PMC5083938. 11: Lee EH, Hui CL, Lin JJ, Ching EY, Chang WC, Chan SK, Chen EY. Quality of life and functioning in first-episode psychosis Chinese patients with different antipsychotic medications. Early Interv Psychiatry. 2016 Dec;10(6):535-539. doi: 10.1111/eip.12246. Epub 2015 May 12. PubMed PMID: 25967146. 12: Crespo-Facorro B, Pelayo-Teran JM, Mayoral-van Son J. Current Data on and Clinical Insights into the Treatment of First Episode Nonaffective Psychosis: A Comprehensive Review. Neurol Ther. 2016 Dec;5(2):105-130. Epub 2016 Aug 23. Review. PubMed PMID: 27553839; PubMed Central PMCID: PMC5130917. 13: Sampford JR, Sampson S, Li BG, Zhao S, Xia J, Furtado VA. Fluphenazine (oral) versus atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev. 2016 Jul 2;7:CD010832. doi: 10.1002/14651858.CD010832.pub2. Review. PubMed PMID: 27370402. 14: Meister R, von Wolff A, Mohr H, Härter M, Nestoriuc Y, Hölzel L, Kriston L. Comparative Safety of Pharmacologic Treatments for Persistent Depressive Disorder: A Systematic Review and Network Meta-Analysis. PLoS One. 2016 May 17;11(5):e0153380. doi: 10.1371/journal.pone.0153380. eCollection 2016. Review. PubMed PMID: 27187783; PubMed Central PMCID: PMC4871495. 15: de Bartolomeis A, Marmo F, Buonaguro EF, Latte G, Tomasetti C, Iasevoli F. Switching antipsychotics: Imaging the differential effect on the topography of postsynaptic density transcripts in antipsychotic-naïve vs. antipsychotic-exposed rats. Prog Neuropsychopharmacol Biol Psychiatry. 2016 Oct 3;70:24-38. doi: 10.1016/j.pnpbp.2016.04.015. Epub 2016 May 10. PubMed PMID: 27177972. 16: Sahlholm K, Zeberg H, Nilsson J, Ögren SO, Fuxe K, Århem P. The fast-off hypothesis revisited: A functional kinetic study of antipsychotic antagonism of the dopamine D2 receptor. Eur Neuropsychopharmacol. 2016 Mar;26(3):467-76. doi: 10.1016/j.euroneuro.2016.01.001. Epub 2016 Jan 14. PubMed PMID: 26811292. 17: Sistik P, Turjap M, Iordache AM, Saldanha HM, Lemr K, Bednar P. Quantification of selected antidepressants and antipsychotics in clinical samples using chromatographic methods combined with mass spectrometry: A review (2006-2015). Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Mar;160(1):39-53. doi: 10.5507/bp.2015.065. Epub 2016 Jan 12. Review. PubMed PMID: 26757776. 18: Ouyang X, Leonards PE, Tousova Z, Slobodnik J, de Boer J, Lamoree MH. Rapid Screening of Acetylcholinesterase Inhibitors by Effect-Directed Analysis Using LC × LC Fractionation, a High Throughput in Vitro Assay, and Parallel Identification by Time of Flight Mass Spectrometry. Anal Chem. 2016 Feb 16;88(4):2353-60. doi: 10.1021/acs.analchem.5b04311. Epub 2016 Jan 26. PubMed PMID: 26754356. 19: Nielsen MØ, Rostrup E, Wulff S, Glenthøj B, Ebdrup BH. Striatal Reward Activity and Antipsychotic-Associated Weight Change in Patients With Schizophrenia Undergoing Initial Treatment. JAMA Psychiatry. 2016 Feb;73(2):121-8. doi: 10.1001/jamapsychiatry.2015.2582. PubMed PMID: 26747088. 20: Chen CY, Yeh YW, Kuo SC, Ho PS, Liang CS, Yen CH, Lu RB, Huang SY. Catechol-O-methyltransferase gene variants may associate with negative symptom response and plasma concentrations of prolactin in schizophrenia after amisulpride treatment. Psychoneuroendocrinology. 2016 Mar;65:67-75. doi: 10.1016/j.psyneuen.2015.12.003. Epub 2015 Dec 8. PubMed PMID: 26724569.